South India's First ZAP-X Neuro-Radiosurgery Platform Revolutionizes Brain Tumor Treatment

AIG Hospitals introduces the ZAP-X Gyroscopic Neuro-Radiosurgery Platform in South India, marking a significant breakthrough in non-invasive brain tumor treatment. The technology offers precise, incision-free radiosurgery, minimizing hospital stays and recovery time, and establishes Hyderabad as a hub for advanced neurological care.

South India's First ZAP-X Neuro-Radiosurgery Platform Revolutionizes Brain Tumor Treatment
AIG Hospitals announces launch of ZAP-X®[?] Gyroscopic Neuro-Radiosurgery Platform (Photo/Release). Image Credit: ANI
  • Country:
  • India

AIG Hospitals today announced the launch of the ZAP-X Gyroscopic Neuro-Radiosurgery Platform, a first for South India and only the second such installation nationwide, heralding a transformative step in brain tumor and neurological disorder treatment. Designed for precision intracranial procedures, ZAP-X offers a revolutionary approach, eschewing incisions for day-care treatment, as per the official statement.

The platform delivers targeted radiation with sub-millimetre accuracy, selectively treating abnormal tissues while sparing healthy areas. This innovation allows for non-invasive, painless treatment, eliminating the need for hospital stays and enabling swift recovery. India faces a growing health challenge with brain tumors, traditionally necessitating intricate surgeries and extended hospitalization. However, stereotactic radiosurgery presents a safer and more efficient alternative.

The introduction of ZAP-X at AIG Hospitals brings elite neuro-radiosurgical capabilities to South India. D. Nageshwar Reddy, Chairman of AIG Hospitals, emphasized their commitment to cutting-edge, patient-centric care, citing the platform as a major advancement. The system caters to a range of conditions, including brain metastases and complex neurological disorders, enhancing treatment precision and outcome quality across the region.

Give Feedback

Use this form for editorial or site feedback. We usually reply within 2 to 3 working days.

By submitting, you agree that we may use your email address to respond.